Related Experiment Videos
Osteoid osteomas with chromosome alterations involving 22q
M R Baruffi1, J B Volpon, J B Neto
1Department of Genetics, School of Medicine of Ribeirão Preto, University of São Paulo, Av. Bandeirantes, 3900, 14049-900, Ribeirão Preto-SP, Brazil.
Cancer Genetics and Cytogenetics
|February 15, 2001
Summary
Cytogenetic analysis revealed distinct chromosomal alterations in two osteoid osteomas. These findings differ from previously reported cases, suggesting varied genetic pathways in osteoid osteoma development.
Area of Science:
- Oncology
- Genetics
- Pathology
Background:
- Osteoid osteoma is a benign bone tumor with typically unremarkable cytogenetics.
- Previous studies have reported limited chromosomal abnormalities in osteoid osteomas.
Observation:
- Two osteoid osteoma cases underwent cytogenetic analysis, both with a modal chromosome number of 46.
- One case showed a sole deletion on chromosome 22 (del(22)(q13.1)).
- The second case exhibited clonal monosomies for chromosomes 3, 6, 9, 17, 19, and 21, along with a non-clonal del(22)(q13.1).
Findings:
- The observed cytogenetic profiles in these two osteoid osteomas are unique and distinct from each other and from the single previously reported case with clonal alterations.
- The chromosomal alterations, particularly numerical changes in chromosomes 3, 6, 9, 17, 19, 21, and 22, are implicated in various neoplasms, including bone tumors.
- The breakpoint on chromosome 22 targets a region containing genes crucial for cell cycle regulation.
Implications:
- These findings highlight the potential for diverse cytogenetic abnormalities in osteoid osteomas, challenging the notion of a uniform genetic profile.
- Understanding these chromosomal alterations may provide insights into the molecular pathogenesis of osteoid osteomas.
- Further research is warranted to explore the functional significance of these genetic changes and their role in tumor development.